Thousands of genetic associations with phenotypes of blood cells are known, but few are with phenotypes relevant to cell function. We performed GWAS of 63 flow-cytometry phenotypes, including measures of cell granularity, nucleic acid content, and reactivity, in 39,656 participants in the INTERVAL study, identifying 2,172 variant-trait associations. These include associations mediated by functional cellular structures such as secretory granules, implicated in vascular, thrombotic, inflammatory and neoplastic diseases. By integrating our results with epigenetic data and with signals from molecular abundance/disease GWAS, we infer the hematopoietic origins of population phenotypic variation and identify the transcription factor FOG2 as a regulator of platelet α-granularity. We show how flow cytometry genetics can suggest cell types mediating complex disease risk and suggest efficacious drug targets, presenting Daclizumab/Vedolizumab in autoimmune disease as positive controls. Finally, we add to existing evidence supporting IL7/IL7-R as drug targets for multiple sclerosis.
INTRODUCTION
Blood cells have functions in a wide variety of physiological processes, most importantly in oxygen transport, hemostasis, and the immune system. There are three principal types of cells in the peripheral blood: red cells, which carry oxygen from the lungs for respiration; platelets, which initiate repair of damaged blood vessels to prevent bleeding; and white cells which clear pathogens through innate and acquired immune processes. These cells are suspended in plasma, an aqueous solution containing glucose, metabolites, hormones and proteins. Many of these proteins have a hematopoietic origin, because biomolecules from mature blood cells routinely diffuse into the plasma during functional processes such as cell activation or granule secretion.
Blood cell function cannot, at present, be measured using high throughput instruments. Consequently, genetic association studies of cell function have been limited to relatively small studies of platelet aggregation phenotypes, which have identified fewer than ten associated variants (Johnson et al . 2010) . High powered genetic association studies of blood cell phenotypes have been performed, but these have concentrated on variables measured in classical complete blood counts (cCBCs) (Astle et al. 2016; Tajuddin et al. 2016; Chami et al. 2016; Eicher et al. 2016) . cCBCs are standard clinical reports, which include standardised counts of the cells in the peripheral blood, measurements of the average volumes of platelets and red cells and measurements of blood hemoglobin concentration and localization. These variables contain a wealth of information about hematopoiesis and blood cell clearance mechanisms, but they were not selected to measure properties of the intracellular structures which participate in clinically relevant cell activation pathways. For example, pathologies of leukopoiesis that result in a lack of specific granules in neutrophils can cause immune dysfunction (Amulic et al . 2012 ) , but such disorders are frequently accompanied by a normal neutrophil count and so are not detected by cCBCs.
We took a new approach to phenotyping biological variation endogenous to blood cells. Modern hematology analyzers (which generate cCBCs reports) contain flow cytometers which measure properties of blood cells by recording disturbances of incident laser light. The Sysmex XN-1000 instrument, for example, treats blood with membrane permeabilizing agents, allowing a nucleic acid staining dye to enter the cells. The fluorescence intensity of light emitted by the dye (termed 'side fluorescence' or SFL) measures the nucleic acid content and membrane permeability of the cell, while the intensities of diffracted light scattered sideways (SSC) and forward (FSC) by the cell measure intracellular organelle complexity and cell size respectively ( Figures 1A-E ) (Zimmermann et al. 2011; Linssen et al . 2008) . When aggregated at the individual level (by median or distribution width), these data provide summary measures of cell structure related to cell function. For example, antigen-stimulated (reactive) lymphocytes can be detected and enumerated using SFL (Henriot et al. 2017) while the activation of neutrophils (NE) with physiological compounds such as formyl-methionyl-leucyl-phenylalanine (fMLP), and lipopolysaccharide (LPS) causes changes in NE-SSC (median neutrophil SSC) and NE-SFL (median neutrophil SFL) (Zimmermann et al. 2011; Linssen et al. 2008) .
Here, we report the first large-scale genome-wide association studies (GWAS) of flow cytometry measured non-classical CBC (ncCBC) traits ( Figure 1F ). We call these phenotypes ncCBC traits, because they were acquired using a hematology analyser (the XN-1000), but are not included in standard cCBC reports. By integrating the results of ncCBC, multi-omic and disease GWAS, we show how flow cytometry traits can be used to elucidate the secretory origins of proteins in the blood plasma, to study biological pathways mediating variation in disease risks and to suggest the cell types of action of drugs.
RESULTS

Hundreds of new genetic determinants of blood cell flow cytometry traits
We studied 63 ncCBC phenotypes, of which 11 summarise measurements of intracellular complexity/granularity (SSC), 16 summarise measurements of cell nucleic acid content/membrane lipid content (SFL) and 15 summarise measurements of cell morphology/volume (FSC) ( Table S1 ). 20 of the traits were platelet phenotypes, 10 were red cell phenotypes and 33 were white cell phenotypes. The effective numbers of uncorrelated platelet, red cell and white cell traits (see STAR★Methods) were 5.2, 11.3 and 28.4 respectively ( Figures S1, S2 ). Furthermore, the effective numbers of additional uncorrelated platelet, red cell and white cell traits, compared to those of the same cell type measured by cCBCs were 3.9, 2.7 and 24.7 respectively, suggesting that the white cell traits collectively measure a greater diversity of novel biology than the platelet and red cell traits ( Figures 2, S3, S4 ). We performed univariable genetic association analyses ( Figure 1F ; Table S1 ), using genotypes imputed for 26.8 million variants in 39,656 European-ancestry blood donors in the INTERVAL study (Moore et al . 2014) . Stepwise regression analysis identified 2,172 distinct (conditional P -value<8.31x10 -9 ) variant-trait associations ( Table S2 ). The application of a standard LD ( r 2 >0.8) based greedy clumping algorithm, partitioned the 1,314 unique variants identified by the stepwise analysis (the conditionally significant variants ) into 849 clusters (clumps), of which 231 contained a platelet associated variant, 211 a red cell associated variant and 432 a white cell associated variant ( Figures 2, S5 ). 74 (32%) of the clumps containing a platelet trait associated variant contained no variant in high LD ( r 2 >0.8) with any of the conditionally significant variants associated with a platelet trait studied by Astle et al. (2016 ) , in the largest GWAS of cCBC phenotypes published to date. Analogously, 54 (26%) of the clumps containing a red cell associated variant and 289 (69%) of the clumps containing a white cell associated variant contained no variant in high LD with a variant associated with a phenotype of the respective cell types in the earlier study of cCBCs ( Figure S6 ). The enrichment of novel associations with white cell traits may be partly explained by the fact that cCBCs include some phenotypes of platelets and red cells that capture cellular morphology (e.g. mean cell volumes), for which there are no white cell analogues. More interestingly, in comparison to platelets and red cells, white cells exhibit substantial biological complexity susceptible to measurement by flow cytometry. Specifically, white cells are nucleated and contain complicated intracellular organelles such as granules and vacuoles which differ according to cell type. Both red cells and platelets are anuclear, and only platelets contain granules.
The effects of associated variants on transcription and cell structure
To identify possible molecular mediators of the association signals, we annotated each conditionally significant variant with the subset of its enveloping or proximal (within 5kb) genes for which the transcriptional consequence predicted by Variant Effect Predictor (VEP) was most severe in the Ensembl ranking (McLaren et al. 2016) . We undertook an extensive search of the literature characterising these genes, which highlighted protein products with fundamental functions in the cell types corresponding to the associations, including thrombus formation for platelet traits (e.g. VWF, SERINE2 ), iron homeostasis for red cell traits (e.g. HFE, TFRC ) and chemotaxis and adhesion for myeloid white cell traits (e.g. P2RY2, SSH2 ) ( Figure 3 ; Table S2 ). A comparison of the genes assigned to the ncCBC associations with those assigned to cCBC associations by Astle et al. (using the same procedure) revealed that 25% of platelet, 25% of red blood cell, and 79% of white blood cell ncCBC gene assignments corresponded to novel associations with the corresponding cell type (red cells, platelets, neutrophils, eosinophils, basophils, monocytes, and lymphocytes). In total we identified 245 genes not reported by Astle et al ., 2016, including, for example, the eosinophil phenotype associated genes CTNS and IFI30 (which respectively code for cystinosin, a lysosomal cystine transporter and gamma-interferon-inducible lysosomal thiol reductase) (West and Cresswell 2013; Guo et al. 2018) .
To assess the usefulness of the VEP annotation, we computed posterior probabilities (PPs) of colocalization between the ncCBC trait association signals and gene expression quantitative trait loci (eQTL) identified in the corresponding cell types. We aggregated imputed genotypes with microarray measurements of gene expression in platelets, neutrophils, monocytes, and CD19 + B, CD4 + T and CD8 + T lymphocytes from five independent studies containing 300-1,490 participants depending on cell type. We searched for variants associated with gene expression in gene specific windows (limited to the gene body and a 1MB extension from each gene boundary) (Kreuzhuber 2018) . After applying stringent analysis criteria (see STAR★Methods) we identified 134 ncCBC variant-trait associations exhibiting strong evidence (PP > 80%) of colocalization with at least one eQTL, corresponding to a total of 65 genes ( Table S3 ). VEP assigned a concordant gene to 79 (81%) of the 97 eQTL colocalizing variant-trait associations unique to a particular cell type. The colocalizing genes include several with well understood biological functions (e.g. ARHGEF3, CD226, CD36 ) ( Figure 3 ), some consistent with a computationally inferred function imputed from protein-protein interaction networks (e.g. HABP4 ) and others for which knowledge of function is limited (e.g. SEC14L5, ZMAT3 ).
We used the Gene Ontology database (The Gene Ontology Consortium 2019) and data from mass spectrometric profiling of neutrophil granules (Rorvig et al., 2013) to identify the subcellular localisation of the products of many of the ncCBC trait associated genes ( Table S4 ). This revealed that proteins mediating the genetic associations reside in a wide variety of organelles including the nucleus, the mitochondria, the endoplasmic reticulum, the Golgi apparatus, the centrosome, vesicles, lysosomes, vacuoles and cytoplasmic granules. Cellular granules are organelles, which are prominent in neutrophils, eosinophils, basophils, and present in monocytes where they play critical roles in innate immune responses by releasing antimicrobial proteins (Borregaard, Sørensen, and Theilgaard-Mönch 2007; Acharya and Ackerman 2014; Becknell et al . 2015; MacGlashan 2013) . We identified genes that code for a number of white cell granule proteins not previously found by GWAS of granulocyte traits, including Arylsulfatase B, Bactericidal permeability-increasing protein, RNase 3 and RNase K6. These proteins have well understood roles in immunity (Borregaard, Sørensen, and Theilgaard-Mönch 2007) , illustrating a limitation of cCBC GWAS as a tool to study the functional properties of blood cells. More generally, we identified 48 associations with NE-SSC (neutrophil granularity), 39 associations with EO-SSC (eosinophil granularity), and 16 associations with MO-SSC (monocyte granularity) that did not correspond to any of the genetic associations with cCBC traits reported by Astle et al . ( Table S2 ). These include associations near genes the functions of which in blood cells are well understood, including roles in transcription and translation ( BCL6, E2F2, EVI5 ), in granule formation and retention ( VAMP3 , VPS26A ), as granule cargo ( ARSB, CTSB, DEFA, PRTN3, PRG2/3, RNASE2/3 ), and in post-translational modifications ( B3GNT2 , CHST11 , DSTYK ). Other associations highlight genes for which knowledge of hematological function is still developing (e.g. PTBP1 , Polypyrimidine tract binding protein 1, which may modulate pre-mRNA proce ssing (Attig et al . 2018 ) and is associated with NE-SSC; TRPS1 , transcriptional repressor GATA binding 1, which functions as a transcriptional repressor, is implicated in human cancers (Wang et al. 2018) and is associated with EO-SSC; VMP1 , vacuole membrane protein 1, which is required for organelle biogenesis, protein secretion, and autophagy (Calvo-Garrido et al . 2008; Zhao et al. 2017) and which is associated with MO-SSC ), confirming that our approach has uncovered biologically interesting candidate genes and molecular pathways modulating granule formation and cellular complexity.
The biogenesis of cellular structures
Many of the intracellular structures generating variation in flow cytometry traits have their origins in the immature precursors of peripheral blood cells. Granule formation for example, is a cell-type specific process known to occur at particular stages of cellular differentiation; the granules of platelets and granulocytes begin to form respectively in megakaryoblasts and myeloblasts. Consequently, the absence of a colocalising mature blood cell eQTL for a cytometry trait association may reflect the fact that the associated genetic variant exerts its effects after lineage commitment, but before terminal differentiation. To test this hypothesis, we applied FINEMAP v1.3.1 (Benner et al. 2016) to identify credible sets of variants causally associated with the ncCBC traits and assessed the enrichment of those variant sets in the nucleosome depleted regions (ATAC-seq) of nine types of progenitor cell (localized in the bone marrow) and nine types of mature cell (generally localized in the peripheral blood) (Ulirsch et al. 2019) . We observed patterns of enrichment in the open chromatin regions of the progenitor cell types ancestral to neutrophils, eosinophils, monocytes, and lymphocytes ( Figure S7A-D ) , which suggest the developmental stage ( Figure S7F ) at which the cell characteristics corresponding to particular traits (SSC, SFL, FSC) develop. For instance, neutrophils, which are the primary anti-microbial cell type, contain three classes of cytotoxic granules -azurophilic, specific and gelatinase -which are formed sequentially at distinct stages of differentiation (Grassi et al. 2018) . The relative enrichments of genetic variants associated with NE-SSC (neutrophil granularity) in the nucleosome depleted regions of the hematopoietic stem cell (HSC) and the four types of myeloid progenitor cell (CMP, GMP-A, GMP-B, GMP-C) are consistent with a progressive increase in the accessibility of enhancers regulating granule formation during myeloid differentiation and point to an origin of these granules in lineage-committed myeloid progenitors ( Figure S7A-F ). In monocytes, we observed an enrichment of MO-SFL (monocyte nucleic acid content) associated variants in the nucleosome depleted regions of monocyte progenitor cells (GMP) consistent with the phase of proliferation and cell division, and an enrichment of MO-SSC (granularity) in the nucleosome depleted regions of peripheral blood monocytes indicating that granularity is regulated in the ultimate stages of monocyte differentiation before egress from the bone marrow.
The cellular origins of plasma proteins
We hypothesized that some genetic variants associated with cytometric traits, in-particular genetic variants associated with side scatter traits, which can capture the abundance of secretory granules in cells, also influence the concentration of proteins in the blood plasma. To explore this, we turned to , a multi-GWAS study which identified 1,927 associations (protein quantitative trait loci, pQTL, Table S4 ) with the plasma concentrations of 1,478 proteins. For 943 of these proteins, there is strong evidence that transcripts are expressed (log scaled fragments per kilobase of transcript per million mapped reads (log 2 FPKM) >1.0) in at least one of the blood cell types surveyed by the ncCBC traits (megakaryocytes (MKs) and erythroblasts, the respective progenitors of platelets and red cells, and neutrophils, eosinophils, basophils, monocytes, CD4 + T cells, CD8 + T cells, naive B cells). We performed colocalization analysis between the pQTL and our cytometry trait-associated variants and identified 61 and 1,021 colocalizations (PP>80%) in cis and trans respectively ( Figure 3 , Table S4 ). 223 plasma proteins had associations colocalizing with just one cell-type suggesting that the hematopoietically derived fraction of these proteins in the plasma originates predominantly from a single blood cell type (e.g. VEGFA , which encodes vascular endothelial growth factor A, is associated with eight different platelet traits, while RNASE6 , which encodes RNase K6, is associated solely with monocyte side fluorescence). Notably, many signals assigned by VEP to genes encoding granule proteins also colocalized with pQTL signals in blood plasma ( Figure 3 ).
RNASE6 (PP=99%) ( Table S5 ). The PRTN3 colocalization illustrates how the genetic associations with cellular and molecular phenotypes can be combined to elucidate disease pathogenesis. rs138303849-C, a variant upstream of PRTN3 (encoding proteinase-3, PR3), is known to be associated with an increased risk of a vasculitis characterised by autoantibodies against PR3 (Merkel et al. 2017 ) . This variant is an eQTL in whole blood (GTEx Consortium 2015) and we recently showed that the risk allele is associated with increased PR3 concentration in plasma . The main source of PR3 in plasma is the specific granule, one of three classes of granule found in neutrophils. In the present analysis, we observed that the risk allele is associated with increased neutrophil SSC (granularity), SFL (nucleic acid), FSC (volume) , and decreased NE-SSC-DW (SSC distribution width); the associations all colocalise with the cis-pQTL for higher plasma PR3 levels (PP=99.9%). This shows that the vasculitis risk allele not only increases PRTN3 transcription and PR3 plasma protein levels, but also changes the structural and functional properties of neutrophils.
Evidence that ZFPM2 is a regulator of platelet α-granularity
Platelet activation is important in thrombus formation, wound healing, inflammation and the chemotaxis and activation of myeloid white cells. Critical to these biological processes are coagulation proteins, growth factors, proteases, chemokines and other signalling peptides that diffuse into the blood plasma when α-granules are released by activated platelets. Our GWAS of PLT-SSC (platelet granularity) identified an association in ZFPM2
(which encodes the transcription factor Friend of GATA-2 or FOG2) ( Figure 4A ), colocalizing with trans pQTLs for 24 plasma proteins ( ANGPT1* , APLP2* ,
LGALS7 , NSG2 , PDGFA* , PDGFB* , PDGFD* , PPBP* , SERPINE1* , SIRT5 , SPARC* , SYT11 , UGT2A1 , VEGFA* ) of which 11 (starred) are platelet α-granule localized proteins ( Table S5 ). RNA-seq of 9 differentiated but nucleated blood cell types (Grassi et al. 2019) showed that transcripts of ZFPM2 are substantially expressed solely in MKs ( Figure 4B ). Complementary data, from a study of the entire hematopoietic system, show that ZFPM2 is specifically expressed in the MK lineage ( Figure 4C ). Stepwise multiple regression analysis of the platelet granularity association (PLT-SSC) suggested a single conditionally significant association signal in an 82kb interval of low recombination. Fine-mapping of the locus identified an intronic SNP (rs6993770) as the most probable causal variant (PP=95%). rs6993770 is located in a region of open chromatin (ATAC-seq) in MKs, which contains histone modifications indicative of enhancers (H3K4 tri-methylation, H3K27 acetylation; Figure 4D , 4E ). The variant is 25bp upstream of a GATA motif on the negative strand, and 34bp upstream from the palindromic E-box binding motif CAGCTG. The juxtaposition of these motifs is characteristic of a hematopoietic co-binding site for GATA1 and TAL1, two of the three key megakaryocyte lineage determining transcription factors (Moreau et al. 2016; Han et al. 2016; Kassouf et al. 2010) . None of the seven variants in high LD ( r 2 > 0.9) with rs6993770 were located in regions for which epigenetic data supported causality in MKs ( Figure 4E ).
There are well known associations between rs6993770 and the four classical platelet traits: platelet count (PLT), volume (MPV), crit (PCT) and volume distribution width (PDW). (Gieger et al. 2011; Astle et al. 2016) . We identified new associations with the ncCBC traits IPF#, PLT-SSC, and PLT-FSC ( Table S2 , Figure 4F ). The estimated effect of rs6993770 on PLT-SSC was not significantly attenuated by a multivariable linear adjustment for the four classical traits, suggesting that the association is not substantially mediated through these traits. Consequently, we hypothesized that ZFPM2 has a role in α-granule control. To examine this, we performed a broad analysis of the plasma concentrations of 1,456 of the proteins studied by for which there was evidence for expression in MKs (RNA-seq log 2 FPKM>1, Figure  4G ) and identified 215 proteins associated with rs6993770 at a relaxed univariable significance threshold ( P -value<10 -3 ). 44 of these 215 proteins are localized in α-granules and the estimated effect of rs6993770-T on the plasma concentration of 91% (40) of these 44 was negative. In contrast rs6993770-T had a negative estimated effect on the plasma concentration of 59% (101) of the 171 proteins not localised in α-granules, showing that the direction of effect of rs6993770-T on the plasma concentration of a protein differs significantly according to its α-granule localisation (Fisher's exact test P -value=3.17x10 -5 ) ( Figure 4H ). To assess whether this differential effect might be explained by a systematic difference in the expression level of genes according to the α-granule localisation of the corresponding proteins, we performed a linear regression of the estimated effect sizes of rs6993770-T on plasma concentration against a dummy variable indicating α-granule localisation, restricting to the 1,456 proteins expressed in MKs (log 2 FPKM>1) and adjusting for the abundance of the mRNA transcripts for the corresponding genes in MKs. We estimated the additive allelic effect of rs6993770-T on plasma proteins to be 0.369 phenotypic standard deviations lower on average ( P -value 8.5x10 -10 ) in proteins localized to α-granules compared to other proteins ( Figure 4H; Figure S8 ). This shows that rs6993770 differentially modifies the plasma concentration of α-granule proteins, possibly by altering ZFPM2 transcript levels in the cellular progenitors of platelets.
Interestingly, Klarin et al. (2017 ) recently reported an association between the T allele of rs6993770 and decreased risk of venous thromboembolism (VTE). They postulated that the underlying mechanism is a ZFPM2 mediated decrease in the plasma concentration of the principal inhibitor of plasminogen activator PAI-1, which is encoded by SERPINE1 (Klarin et al. 2019) . The notion that lower levels of plasma PAI-1 cause a reduced risk of VTE is biologically plausible. However, we have shown that rs6993770 is pleiotropic, modifying the process of platelet formation and platelet granule content and the concentrations of many platelet derived proteins in the blood plasma ( Figure 4F ), highlighting the importance of broader multi-trait and multi-omic analysis, for etiological inference and the characterization of disease risk association signals.
Elucidating disease etiology and inferring drug targets
We hypothesized that genetic associations with ncCBC traits could improve our understanding of etiological cell types and molecular mechanisms more generally. We chose to focus on immune, inflammatory and cardiovascular diseases, in which blood cells are known to play a causal role. We retrieved publicly available GWAS summary statistics for 26 diseases (Kundu et al . 2020 ) and assessed the evidence for colocalization between genetic associations with ncCBC traits and disease risks ( Table 1 ) (Pickrell et al. 2016) . We found strong evidence (PP>80%) for colocalization between 73 of the variant-ncCBC trait associations (in 29 LD clumps) and at least one disease association ( Table S6 ).
The ncCBC GWAS identified 153 variant-trait associations (in 101 LD clumps) with lymphocyte traits, of which 15 (in 8 LD clumps) colocalized with at least one genetic association with the risks of multiple sclerosis (MS), celiac disease, primary biliary cirrhosis, hay fever/rhinitis or coronary artery disease ( Table S6 ). 12 of these colocalizations (in 5 LD clumps) were with associations for risk of MS, recapitulating the known importance of lymphocytes in the etiology of MS (Legroux and Arbour 2015) . The colocalizing associations were located in the transcription factor encoding gene BACH2 , in the genes encoding receptors for Interleukin(IL)-2 (IL2RA) and IL-7 (IL7R) and in IL-7 itself. IL-2 receptor α-chain (the product of IL2RA) is a known therapeutic target for MS. The IL2RA colocalising association rs3118471-G (PP=99.9%, AF=30%) corresponds to reduced LY-SSC and an increased risk of MS (International Multiple Sclerosis Genetics Consortium et al. 2011) . IL2RA is the target of the therapeutic antibody Daclizumab, which is known to be clinically effective in the treatment of MS (Wynn et al . 2010; Bielekova et al. 2004 ) , but has been withdrawn due to severe side effects including encephalitis (Stork et al. 2019; Bielekova et al. 2006) ; (Giovannoni et al. 2016; Curto et al. 2016; Abbas et al. 2011) . A second antibody used to treat MS (Natalizumab), which targets the α4β1 integrin, has been associated with a small number of cases of progressive multifocal leukoencephalopathy (PML), but is still licensed (Bloomgren et al . 2012) . The risk of developing PML is greater for patients with antibodies against the JC virus.
Alternative therapeutic approaches for MS are required to ameliorate the risk that subsets of patients develop severe side effects on existing drugs. The IL-7 receptor (the product of IL7R ) is one possible target (Lee et al. 2011; Bielekova et al. 2006) . Preclinical studies in mice show that blockade of IL-7R can ameliorate MS severity (Lawson et al. 2015) . Genetic evidence suggests that increasing serum concentration of soluble IL-7R increases the risk of multiple sclerosis (Galarza-Muñoz et al. 2017) . The colocalising association in IL7R with reduced risk of MS is with rs11567705-G (PP=95.7%, AF=27.5% ) and the variation in risk is thought to be mediated by a reduction in the soluble isoform of the receptor in favour of the membrane bound isoform (Gregory et al. 2007; International Multiple Sclerosis Genetics Consortium et al . 2011) . Our analysis shows that the association with reduced MS risk colocalizes with an association with decreased RE-LYMP#, a direct measure of the peripheral blood concentration of reactive lymphocytes. Thus our analysis supports the hypothesis that the etiological effect can be explained by the modulation of T-cell activation and provides further support for IL-7R/IL-7 as an efficacious target for MS treatment (Gregory et al . 2007 ) .
Three of the 98 variant trait-associations (in 69 LD clumps) with ncCBC phenotypes of monocytes colocalised with disease risk associations, two in ATXN2 and one in ITGA4, all with inflammatory bowel disorder (IBD) associations. An antibody against integrin α4β7 (encoded by ITGA4 / ITGB7 ), Vedolizumab, is used to treat IBD Feagan et al. 2013) . It is assumed to reduce trafficking of α4β7-positive gut-specific T-helper lymphocyte by diminishing integrin interaction with the mucosal addressin cell adhesion molecule 1 (MadCAM-1) (Soler et al. 2009; Rogler 2018) . However, a recent study has suggested that the antibody also reduces the ability of monocytes to egress into the colonic mucosa as an alternative mechanism (Rogler 2018; Zeissig et al . 2018; Schippers et al. 2016) . We observed an association in ITGA4 between rs2124440-A (AF=55.3%) and increased MO-SFL-DW, a measure of the within individual variation of the nucleic acid content of monocytes, and a (sub-critical) association with reduced MO-SFL ( P -value=2x10 -8 ). The MO-SFL association is consistent with the co-localization of the associations with an eQTL decreasing ITGA4 transcript abundance in monocytes (PP=99.7%). These observations support the hypothesis that the association with IBD in ITGA4 is partly mediated by monocytes and suggests a non-canonical pathway for the therapeutic effect of Vedolizumab, specifically the inhibition of monocytes.
DISCUSSION
Over the last decade, GWAS have identified thousands of genetic variants associated with common complex disease risks. However, only a fraction of the biological mechanisms generating these associations are understood, partly because the mediating cell-types and tissues are unknown. For many disease associations blood is a good candidate as a mediating tissue. Blood cells, for instance, are known to play roles in the aetiologies of type 1 diabetes, rheumatoid arthritis, lupus erythematosus, MS, IBD, coronary artery disease and thrombotic stroke. One approach to identifying cell types that might mediate a genetic association with disease is to search for cell type specific associations of the corresponding variant with molecular phenotypes. Colocalization of an eQTL, for example, can suggest a causal gene, cell type and tissue. Unfortunately, molecular intermediate traits such as transcript abundances are expensive to measure and, because it is difficult to sort cells from heterogeneous tissues, their QTLs are often identified from association analysis based on abundance data measured from mixtures of cell types (GTEx Consortium 2015) .
We took a complementary approach to molecular phenotyping, using high-throughput flow cytometry to measure 63 ncCBC traits, which capture variation in an array of cell type specific biological processes including transcriptional activity, granule formation, cell degranulation and cell reactivity, in approximately forty thousand healthy blood donors. GWAS analyses of these traits showed that they are heritable, have complex genetic architectures and are affected by variation in genes implicated in a great variety of molecular and cellular pathways perturbing the cellular structures that disturb the laser light as cells pass through a cytometer. One result of this broad biological sensitivity is that cytometry traits have coarser interpretations than intermediate phenotypes of molecular abundance (e.g transcriptomics, proteomics or lipidomics). For example, although cytometry measured 'neutrophil granularity' depends on the average number of granules in peripheral blood neutrophils, our results suggest it also depends on the expression of genes corresponding to proteins localized in granules (e.g. ELANE, MPO, PRTN3 ). Consequently, genetic associations with ncCBC cytometry traits can be used in two ways -either as proxies for cis associations with molecular abundance phenotypes, with the target gene/protein infered by physical location, or as a means to identify the key genes regulating the formation and retention of intracellular structures. The latter purpose is exemplified by our multi-omic analysis of the association in ZFPM2 with PLT-SSC (platelet granularity), which we used to show that the transcription factor FOG2 is a probable regulator of platelet α-granularity, mediating variation in the concentrations of a multitude of α-granule proteins in the blood plasma. α-granule cargo compounds are key to the regulation of thrombus formation, wound healing and thrombus resolution, illustrating that genetic analysis of blood cell cytometry traits can be used to draw inferences about fundamental cellular physiology relevant to cell function.
The integration of our GWAS results with associations from complex disease GWAS demonstrates how ncCBC association signals can capture valuable information about disease etiology, including information useful for drug development. For example, we have shown that genetic associations at particular loci provide evidence supporting the known roles of neutrophils in the etiology of vasculitis, and of lymphocytes in the etiology of MS. We have also shown that the traits can be used to recapitulate the protein and cell-type targets of drugs. Specifically those of Daclizumab (withdrawn due to side effects), which targets the receptor for IL-2 in activated T lymphocytes to treat MS, and those of Vedolizumab which targets the integrin α4β7, to treat IBD. Finally, we have identified human genetic evidence to support data from previously published studies suggesting that targeting IL-7R to reduce reactive lymphocyte count could be efficacious as a treatment for MS. Astle et al. (2016) ) with which it has maximal absolute phenotypic correlation in the study sample. These cCBC traits have been used to group the ncCBC traits into separate subplots. The bar plot on the right of each subplot indicates the number of distinct (conditionally significant) associations for each cytometry trait and the number of those that share an LD clump with a variant reported to be associated with a blood trait of the same cell type by Astle et al. ('Not Novel') . The white cell traits have lower genetic and trait correlation with their corresponding cCBC traits than the red cell and platelet traits, which is reflected in the distribution of new signals across traits.
Figure and Table Legends
Figure 3. Summary of Biological Functions of VEP Assigned Genes Identified by a Survey of the Literature
Each panel contains a list of genes, assigned by VEP or by eQTL/pQTL colocalization, to genetic associations with traits corresponding to the given cell type, for which a literature search identified evidence of known function. Each list is stratified into functional categories relevant to the cell type. Table S2 contains a complete list of conditionally significant associated variants, their VEP annotated genes, and relevant references to literature. The coloured symbolic annotations indicate genes assigned to variants which colocalise with eQTL (blue square), pQTL (orange circle), or disease GWAS associations (purple triangle). An eQTL or pQTL colocalization may be with a cis signal for a nearby gene, which may differ from the gene assigned by VEP. Abundance of ZFPM2 transcripts (log 2 FPKM) in megakaryocytes, erythroblasts, neutrophils, eosinophils, basophils, monocytes, CD4+ naive, CD8+, and naive T cells, showing that of these cell types ZFPM2
transcription is limited to megakaryocyte cells (Grassi et al. 2019) . C. ZFPM2 transcript expression is higher in platelets, megakaryocyte and relevant precursor cells MEP (megakaryocyte-erythroid progenitor cell), CMP (common myeloid progenitor), MPP (multipotent progenitor), and HSC (hematopoietic stem cell) compared to other blood cells and blood cell precursors. D. The ZFPM2 locus remains accessible as assessed by ATAC-seq in a range of blood cell precursors, in particular platelet and megakaryocyte precursor cells MEP, CMP, MPP, and HSC. E. Epigenetic activity in MKs across the 82kb recombination interval containing the association signal. The x -axis shows physical position on chromosome 8. The location of rs6993770 is indicated by the dark vertical line, the nearby light vertical lines indicate the locations of seven variants in high LD ( r 2 > 0.9) with rs6993770. The y -axis of each panel measures sequencing read depth from an epigenetic assay. From top to bottom the panels correspond to ATAC-seq (open chromatin), H3K27ac (a mark of active enhancers) and H3K4me3 (a mark of accessibility to transcription factors). The blue rectangles at the bottom of the figure indicate the enhancer regions inferred from a set of six histone modifications (H3K4me1, H3K4me3, H3K9me3, H3K27ac, H3K27me3 and H3K36me3) in MKs using the IDEAS chromatin segmentation algorithm (Zhang et al. 2016; Petersen et al. 2017) . The green rectangle indicates the position of exon 4 of ZFPM2. F. Forest plot showing the per allele effect of rs6993770-T on the means of the inverse rank normalized distributions of the platelet traits PLT# (platelet count), PCT (plateletcrit), MPV (mean platelet volume), PDW (platelet distribution width), IPF# (immature platelet fraction count), PLT-FSC (platelet volume), and PLT-SSC (platelet granularity) measured in the INTERVAL study. Circular symbols indicate estimates of the marginal effect, triangular points indicate estimates of the effect adjusted for PLT-SSC, square symbols indicate estimates of the effect adjusted for PLT#, PCT, MPV, and PDW. Horizontal lines correspond to 95% confidence intervals. The effect of rs6993770-T on PLT-SSC and PLT-FSC does not appear to be substantially mediated through the cCBC parameters. G. Venn diagram cross classifying the 1,456 genes that are expressed in MKs (transcript log 2 FPKM>1) and code for plasma proteins significantly ( Pvalue < 10 -3 ) associated with rs6993770-T. The classifying categories indicate a) implicated as an α-granule protein coding gene by a literature review b) a protein coded for by the gene was undetected by mass spectrometry of gray platelet syndrome patients' platelets (which lack α-granules) but detected in healthy volunteers and c) protein expelled from activated platelets (platelet releasate). H. The estimated per allele effect of rs6993770-T on the mean concentration of 1,456 plasma proteins with coding genes transcribed in MK cells (log 2 FPKM>1). The y -axis measures the per allele effect size and the x -axis its rank. Bars corresponding to proteins located in platelet α-granules are colored red. Proteins with ranks in the tails bounded by the dashed lines exhibit significant evidence for an association with rs6993770-T at a relaxed critical threshold ( Pvalue < 10 -3 ). α-granule proteins are significantly (embedded P -value) enriched in the negative compared to the positive tail. Table 1 . Cytometry Associations that Colocalise with Genetic Associations with Disease Risk. Each row corresponds to a conditionally independent association with cytometry parameters of a cell type and assigned to independent signals by a LD clumping procedure. We also tested for common causal variants between loci of association with Sysmex parameters and disease risk GWAS, blood cell eQTL, and blood plasma pQTL signals. Results show genetic determinants of cytometry parameters have concomitant effects on disease risk. Heatmap of the genetic correlation calculated between all 63 cytometry parameters, where genetic correlation ranges between -1 and 1 and is calculated from a subset of 63.4 million common variants across the genome in the INTERVAL cohort by LD score regression . This figure shows limited genetic correlation between parameters of white cells with higher genetic correlation between platelet and red cell parameters and very little correlation between parameters of different cell types. Starred correlations are those insufficiently strong to fall below a Bonferroni significance threshold ( Pvalue < 1.28x10 -5 ). Figure S2 . Genetic correlation with clinical full blood count parameters. Heatmap of the genetic correlation calculated between 63 cytometry parameters and all hematological traits studied by Astle et al. (2016) where genetic correlation ranges between -1 and 1 and is calculated from a subset of 63.4 million common variants across the genome in the INTERVAL cohort by LD score regression . This figure shows limited genetic correlation between cytometry traits and previously studied standard hematological traits. Starred correlations are those insufficiently strong to fall below a Bonferroni significance threshold ( Pvalue < 2.27x10 -5 ). Figure S3 . Phenotypic correlation with clinical full blood count parameters. Heatmap of the Pearson correlation between all 63 cytometry phenotypes and FBC traits (Astle et al. 2016 ) adjusted for technical and environmental covariates, showing limited correlation between cytometry parameters and FBC parameters of white cells and higher correlation for platelet and red cell related parameters. Figure S4 . Phenotypic correlation within cytometry parameters.
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Heatmap of the Pearson correlation between all 63 cytometry phenotypes showing stronger trait correlation adjusted for technical and environmental covariates between phenotypes of red cell and platelet traits than between phenotypes of white cells and low trait correlation between parameters of different cell-types. Figure S5 . Distribution of LD clumps across cell types. Distribution of LD clumps across cell types showing limited overlap (31 sets) between LD clumps assigned to different cell types suggesting that the cytometry traits are driven by cell type specific genetic determinants. Figure S6 . Distribution of LD clumps within a cell type. Distribution of LD clumps between cytometry traits within a cell type showing limited overlap between the genetic determinants of different cytometry traits (SSC, SFL, FSC, associated distribution width measures, and relevant count measure) of the same cell type. These results show that cytometry traits are influenced by distinct genetic determinants. Figure S7. ATAC-seq enrichment analysis for neutrophils, eosinophils, monocytes, and lymphocytes. A-D) Cell type specific enrichments for FINEMAP 95% credible set variants associated with cytometry parameters. E) Legend for panels A-D showing cells from the hematological tree for which specific epigenomic data were assayed. F) Diagram of hematological tree corresponding to the hematological cell-type labels displayed in E). Figure S8 . Distribution of effect sizes for association of rs6993770-T with plasma protein concentration. We obtained the effect of rs69933770-T on the concentration of 1,472 plasma proteins. The effect of rs6993770-T on plasma concentration was lower on proteins expressed in MKs compared to all proteins and lower still on proteins expressed and localised to α-granules. The allelic effect of rs6993770 on plasma proteins localized to α-granules is on average 0.369 phenotypic standard deviations lower ( P -value 8.5x10 -10 ), showing that rs6993770-T differentially reduces the plasma concentration of plasma α-granule proteins. 
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